ELUT
ELUTIA INC.
Biological Products, (No Diagnostic Substances)Nasdaq<br>Emerging growth company
Total Trades
16
Buys
16
Sells
0
Largest Trade
N/A
Insiders
8
Institutional Funds
24
Inst. Value
$1M+
Activist Filings
1
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| RAKIN KEVIN | Director | BUY | $50K–$100K | 70K | $1.06 | Feb 2, 2026 |
| NEELS GUIDO J | Director | BUY | $15K–$50K | 20K | $1.04 | Feb 2, 2026 |
| NEELS GUIDO J | Director | BUY | $15K–$50K | 30K | $1.06 | Jan 29, 2026 |
| RAKIN KEVIN | Director | BUY | $15K–$50K | 50K | $0.52 | Dec 19, 2025 |
| Colpman David | Director | BUY | $1K–$15K | 13K | $0.51 | Dec 18, 2025 |
| Makes Brigid | Director | BUY | $1K–$15K | 25K | $0.52 | Dec 18, 2025 |
| Mills C Randal | PRESIDENT AND CEO | BUY | $1K–$15K | 3K | $0.51 | Dec 18, 2025 |
| Ferguson Matthew | CHIEF FINANCIAL OF… | BUY | $15K–$50K | 60K | $0.53 | Dec 18, 2025 |
| Ferguson Matthew | CHIEF FINANCIAL OF… | BUY | $1K–$15K | 10K | $0.66 | Dec 3, 2025 |
| Mills C Randal | PRESIDENT AND CEO | BUY | $1K–$15K | 5K | $0.60 | Nov 26, 2025 |
| Colpman David | Director | BUY | $1K–$15K | 16K | $0.74 | Nov 19, 2025 |
| Mills C Randal | PRESIDENT AND CEO | BUY | $1K–$15K | 14K | $0.75 | Nov 14, 2025 |
| HighCape Capital, L.P. | Director | BUY | $1M+ | 420K | $2.50 | Mar 13, 2025 |
| HighCape Capital, L.P. | Director | BUY | $1M+ | 420K | $2.50 | Mar 13, 2025 |
| HighCape Capital, LLC | 10% Owner | BUY | N/A | 2.8M | — | Oct 5, 2023 |
| HighCape Capital, L.P. | Director | BUY | N/A | 2.8M | — | Oct 5, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 24 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Nantahala Capital Management, LLC | 3.2M | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.8M | $1M+ | SH |
| Knollwood Investment Advisory, LLC | 2.6M | $1M+ | SH |
| Alyeska Investment Group, L.P. | 1.3M | $500K+ | SH |
| AIGH Capital Management LLC | 1.1M | $500K+ | SH |
| PERKINS CAPITAL MANAGEMENT INC | 781K | $500K+ | SH |
| Birchview Capital, LP | 263K | $100K–$500K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 213K | $100K–$500K | SH |
| VANGUARD GROUP INC | 126K | $50K–$100K | SH |
| RENAISSANCE TECHNOLOGIES LLC | 102K | $50K–$100K | SH |
| Rossmore Private Capital | 50K | $15K–$50K | SH |
| FNY Investment Advisers, LLC | 37K | $15K–$50K | SH |
| JANE STREET GROUP, LLC | 30K | $15K–$50K | SH |
| HRT FINANCIAL LP | 23K | $15K–$50K | SH |
| Verdence Capital Advisors LLC | 19K | $1K–$15K | SH |
| Tufton Capital Management | 15K | $1K–$15K | SH |
| Indie Asset Partners, LLC | 13K | $1K–$15K | SH |
| STATE STREET CORP | 12K | $1K–$15K | SH |
| MORGAN STANLEY | 8K | $1K–$15K | SH |
| BlackRock, Inc. | 4K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Alyeska Investment Group, L.P.
SC 13G/A · Feb 17, 2026
3.2%
1.3M shares